Eton Pharmaceuticals Inc.

NASDAQ: ETON · Real-Time Price · USD
17.15
0.45 (2.69%)
At close: Aug 15, 2025, 12:51 PM

Eton Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
39.01M 31.64M 21.25M 21.83M
Cost of Revenue
15.6M 10.58M 6.93M 2.62M
Gross Profit
23.41M 21.06M 14.32M 19.21M
Operating Income
-2.6M -1.19M -8.26M -1.5M
Interest Income
n/a n/a 761K 1.01M
Pretax Income
-3.81M -689K -9.02M -1.96M
Net Income
-3.82M -936K -9.02M -1.96M
Selling & General & Admin
22.75M 18.93M 18.58M 14.47M
Research & Development
3.25M 3.32M 4M 6.24M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
26.01M 22.25M 22.58M 20.7M
Interest Expense
2M 1.06M 955K 1.01M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
41.61M 32.83M 29.51M 23.33M
Income Tax Expense
15K 247K 761K 1.01M
Shares Outstanding (Basic)
25.89M 25.64M 25.15M 25.21M
Shares Outstanding (Diluted)
25.89M 25.65M 25.15M 25.21M
EPS (Basic)
-0.15 -0.04 -0.36 -0.08
EPS (Diluted)
-0.15 -0.04 -0.36 -0.08
EBITDA
-1.45M -291K -6.49M -1.12M
EBIT
-2.6M -1.19M -8.26M -1.5M
Depreciation & Amortization
1.15M 901K 1.76M 374K